Device Sectors
Subscribe to Device Sectors
View Sample

FREE Email Newsletter

First Patients Treated in No-Drain Clinical Study of Cohera Medical's TissuGlu Surgical Adhesive

July 12, 2012 10:50 am | News | Comments

Cohera Medical, Inc.®, a leading innovator and developer of absorbable surgical adhesives and sealants, today announced the start of a no-drain clinical trial in 30 patients at two prominent surgery centers in Germany. The study will investigate the safety and effectiveness of TissuGlu® Surgical Adhesive...

Neurostimulation Devices Market to Expand with Growing Patient Pool

July 12, 2012 10:46 am | News | Comments

The neurostimulation devices market can expect impressive gains over the next few years, as the global number of individuals with neurological conditions continues to rise, states a new report by healthcare experts GBI Research.

Advances and Evolution of Medical Visualization Techniques – 3D endoscopy

July 11, 2012 1:38 pm | by Dr. Euan Morrison | Articles | Comments

Historically, surgical technology has been characterized as relatively conservative with low levels of innovation. With a number of ground-breaking developments, no longer is this the case. One particularly interesting area that has advanced recently is the field of 3D endoscopy, where visualization technology is transforming the tools available to surgeons and the effectiveness of their procedures. This, together with some of the other visualization technologies being developed, puts us on the brink of a technology revolution within the surgical device arena.


DSM’s VitroStealth Coating used in Axis-Shield’s next generation Afinion Point-of-Care Cartridge

July 10, 2012 12:22 pm | News | Comments

DSM, a global leader in biomedical materials, today announced that its VitroStealth® non-biofouling coating is used in Afinion®, Axis-Shield’s next generation point-of-care diagnostic system. Physicians can use Afinion® during the span of an office visit and obtain patient lipid levels within a matter of minutes.

Brain Tumor Removal Device Cleared for Use in New Zealand

July 10, 2012 10:38 am | News | Comments

An automated tissue and brain tumor removal device has been approved for use in New Zealand, possibly impacting the estimated 250 primary and 1,500 secondary brain tumors diagnosed every year in the country.

HSCA Applauds FDA for Releasing Proposed Rule on Medical Device Identifiers

July 9, 2012 11:45 am | News | Comments

Healthcare Supply Chain Association (HSCA) President Curtis Rooney today released the following statement regarding FDA’s release of a proposed rule on a Uniform Device Identifier (UDI) for implantable medical devices...

FDA Clears Cook Medical’s Evolution Colonic Controlled-Release Stent

July 9, 2012 10:58 am | News | Comments

The U.S. Food and Drug Administration (FDA) has granted Cook Medical 510(k) clearance for the Evolution® Colonic Controlled-Release Stent, Cook announced today. The new stent expands Cook's line of Evolution controlled-release stents...

Operating Rooms Given Makeover

July 9, 2012 10:11 am | News | Comments

Operating rooms (ORs) are due to see a technological makeover, as healthcare spending cuts and an increased elderly population demands that surgery be as efficient as possible, claims a new report by medical experts GlobalData.


BioView and ScreenCell Announce Worldwide Commercial Collaboration Agreement for Circulating Tumor Cell (CTC) Technology

July 9, 2012 8:31 am | by The Associated Press | News | Comments

BioView Ltd. (TASE: BIOV) and ScreenCell, a privately-held company, today jointly announced the signing of a commercial collaboration agreement for Bioview's Automated Cell Imaging Systems for imaging of CTC's isolated with ScreenCell's Cyto Kit @. Dr. Alan Schwebel, President and CEO of...

Greatbatch proposes to mostly exit Switzerland for Indiana, Mexico

July 3, 2012 11:38 am | by Mass Device | News | Comments

Greatbatch, blaming a slumping orthopedics market and downward pricing pressure from customers, proposes to lay off 90% of its workers at 2 plants in Switzerland, aiming to relocate most of the operations to Indiana and Mexico. Greatbatch (NYSE:GB) said it wants to largely shutter a pair of plants in Switzerland and relocate their operations to Ft. Wayne, Ind., and Tijuana, Mexico. News Well, Mergers & Acquisitions, Orthopedics, Wall Street Beatread more

Guidance for Industry and FDA Staff - Clinical Performance Assessment: Considerations for Computer-Assisted Detection Devices Applied to Radiology Images and Radiology Device Data - Premarket Approval (PMA) and Premarket Notification [510(k)] Submissions

July 3, 2012 12:00 am | by U.S. Food & Drug Administration | News | Comments

This guidance document provides recommendations to industry, systems and service providers, consultants, FDA staff, and others regarding clinical performance assessment of computer-assisted detection (CADe1) devices applied to radiology images and...

Manufacturing Source Provides Product Enhancements And Precision Machining Of 22 Different Components

July 2, 2012 4:36 pm | by Liam Quirke | Articles | Comments

Marshall Manufacturing Company was chosen by Dr. Emil Verban to manufacture the patented Drillstops®, which increase the safety and precision of dental implant procedures. In use, a tiny set-screw locks the stop to the drill bit, the stop rotates with the drill bit while avoiding tissue damage as the drill penetrates the bone.

NeuroSigma Receives Global Quality Control Certification

July 2, 2012 3:53 pm | News | Comments

Today NeuroSigma, Inc., a Los Angeles-based medical device company, announced that it received ISO 13485: 2003 certification, indicating that it operates a Quality Management System for the design, manufacturing and distribution of its external Trigeminal Nerve Stimulation (eTNS™) system for the treatment of neurological and neuropsychiatric disorders.


InVivo targets $22B injectable pain-relief market | Regulatory Roundup

July 2, 2012 3:06 pm | by Mass Device | News | Comments

InVivo Therapeutics engages the FDA to discuss the regulatory path for its injectable hydrogel for neurological pain, anticipating an annual market potential of $22 billion.  InVivo engages the FDA to move forward on injectable pain-relief hydrogen, aims for $22B yearly market News Well, 510(k), Food & Drug Administration (FDA), Pain Management, Regulatory/Complianceread more

Study on Using the NanoKnife System to Treat Liver Tumors Adjacent to Blood Vessels

July 2, 2012 10:18 am | News | Comments

AngioDynamics, a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced the publication of a study in the Journal of the American College of Surgeons, titled, "Ablation of Perivascular Hepatic Malignant Tumors with Irreversible Electroporation."

Medical Device Tax: The road to 60 repeal votes

June 29, 2012 4:26 pm | by Mass Device | News | Comments assesses thechance that the U.S. Senate will vote to repeal the medical device tax. Now that the U.S. Supreme Court has upheld healthcare reform, hopes for a repeal of the medical device tax contained in the law rest with the U.S. Senate and a bill sponsored by Sen. Orrin Hatch (R-Utah) to do away with the 2.3% levy. News Well, Medical Device Taxread more

FSS lands extended CE Mark for FlexStent | Regulatory Roundup

June 29, 2012 2:21 pm | by Mass Device | News | Comments

Flexible Stenting Solutions touts CE Mark approval for additional sizes of its FlexStent self-expanding iliac stents.  FSS touts CE Mark win for new self-expanding stent sizes News Well, 510(k), CE Mark, Food & Drug Administration (FDA), Regulatory Roundup, Regulatory/Complianceread more

SCOTUS Reaction Survey: 66.5% of Primary Care Physicians Fear Individual Mandate Won’t Work

June 29, 2012 10:58 am | News | Comments

In an MDLinx survey of U.S. primary care physicians taken Thursday following the Supreme Court’s upholding of the Affordable Care Act (ACA) ruling, 66.5 percent said that they did not believe the law could achieve its objective of 100 percent healthcare coverage for Americans.

Supreme Court Decision to Uphold Healthcare Law Means “Game On” for Health Industry: Crunch Time for Those Who Waited, Says PwC

June 29, 2012 9:51 am | News | Comments

Today’s Supreme Court ruling upholding the Affordable Care Act gives extra punch to the market forces pushing healthcare away from fee-for-service and re-injects a new sense of urgency into the transformation of the health industry, according to a report published today by the Health Research Institute (HRI) of PwC US.

Supreme Court Ruling Leaves Medical Device Excise Tax in Place: Kalorama

June 28, 2012 3:06 pm | News | Comments

While supporters and opponents of President Obama’s healthcare reform legislation let out boos or cheers for the recent decision of the United States Supreme Court, one industry will not be pleased, according to Kalorama Information. The healthcare market research publisher says that the medical device industry will face additional costs

Generation Opportunity President Paul T. Conway Statement: Scotus Health Care Decision's Impact on Young Americans

June 28, 2012 2:19 pm | News | Comments

Generation Opportunity President Paul T. Conway, former Chief of Staff for the US Department of Labor and former Deputy Secretary of Health and Human Resources for the Commonwealth of Virginia, has issued the following statement regarding the Supreme Court's decision today on the Patient Protection and Affordable Care Act:

Cook Medical Statement on Supreme Court Ruling on Affordable Healthcare Act

June 28, 2012 2:06 pm | News | Comments

With the U.S. Supreme Court ruling upholding the constitutionality of the Affordable Care Act (ACA), Cook Medical now calls for the U.S. Senate to repeal the 2.3 percent medical device excise tax included in that legislation.

EndoGastric Solutions Announces Second Randomized Controlled Trial Comparing TIF Procedure to PPI Therapy for the Treatment of GERD

June 28, 2012 2:02 pm | News | Comments

EndoGastric Solutions® (EGS), the leader in endoluminal treatment of Gastroesophageal Reflux Disease (GERD), today announced the start of the TIF versus Medical Proton Pump Inhibitor (PPI) Management of Refractory GERD Symptoms (TEMPO) trial. TEMPO, the second in a series of randomized trials involving TIF, is designed to assess the safety and efficacy of the procedure—performed using EndoGastric Solutions’ EsophyX® device—as compared to PPI therapy to treat bothersome symptoms associated with chronic GERD.

NLT SPINE Reports Positive Clinical Results for PROW FUSION, Its Lumbar Interbody Fusion Device for Minimally Invasive Spine Surgery

June 28, 2012 1:57 pm | News | Comments

NLT SPINE, a developer of products for Minimally Invasive Spine Surgery (MISS) and percutaneous procedures, announced today that initial results from clinical experience with its PROW FUSION device are highly positive.

Patients Are the Victors in Affordable Care Ruling, Says American Heart Association CEO

June 28, 2012 12:10 pm | News | Comments

American Heart Association CEO Nancy Brown issued the following statement today on the U.S. Supreme Court's ruling upholding the Affordable Care Act: "The historic decision handed down today will benefit America's heart health for decades to come. Questions about the Affordable Care Act's constitutionality have overshadowed the law's progress. With this ruling, that uncertainty has finally been put to rest.

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.